Expression of podoplanin in primary and metastatic poorly differentiated and undifferentiated carcinomas of the head and neck

Anticancer Research

Volumn 32, Issue 5, 2012, Pages 2019-2022

  Friedrich, Reinhard E ^a   Bartel Friedrich, Sylva ^b   Hagel, Christian ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Epstein Barr virus; Head and neck cancer; Nasopharyngeal carcinoma; Podoplanin; Undifferentiated carcinoma

Indexed keywords

PODOPLANIN;

ARTICLE; CANCER PATIENT; CELL DIFFERENTIATION; CELL MOTILITY; CONTROLLED STUDY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS EPITHELIUM;

CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE GLYCOPROTEINS; NEOPLASM METASTASIS;

EID: 84861518076     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Rottey S, Madani I, Deron P and van Belle S: Modern treatment for nasopharyngeal carcinoma: current status and prospects. Curr Opin Oncol 23: 254-258, 2011.
2. Hansen O, Overgaard J, Hansen HS, Overgaard M, Höyer M, Jörgensen KE, Bastholt L and Berthelsen A: Importance of overall treatment time for the outcome of radiotherapy of advanced head and neck carcinoma: dependency on tumor differentiation. Radiother Oncol 43: 47-51, 1997. (Pubitemid 27191978)
3. Zhou CX, Gao Y, Johnson NW and Gao J: Immunoexpression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in the metastasis of squamous cell carcinoma of the human tongue. Aust Dent J 55: 385-389, 2010.
4. Kahn HJ and Marks A: A novel monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. Lab Invest 82: 1255-1257, 2002. (Pubitemid 35014860)
5. Fukunaga M: Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours. Histopathol 46: 396-402, 2005.
6. Schacht V, Dadras SS, Johnson LA, Jackson DG, Hong YK and Detmar M: Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol 166: 913- 921, 2005.
7. Gomaa AHA, Yaar M and Bhawan J: Cutaneous immunoreactivity of D2-40 antibody beyond the lymphatics. Am J Dermatopathol 29: 18-21, 2007. (Pubitemid 46220234)
8. Ohno F, Nakanishi H, Abe A, Seki Y, Kinoshita A, Hasegawa Y, Tatematsu M and Kurita K: Regional difference in intratumoral lymphangiogenesis of oral squamous cell carcinomas evaluated by immunohistochemistry using D2-40 and podoplanin antibody: an analysis in comparison with angiogenesis. J Oral Pathol Med 36: 281-289, 2007. (Pubitemid 46632611)
9. Kawaguchi H, El-Naggar AK, Papadimitrakopoulou V, Ren H, Fan YH, Feng L, Lee JJ, Kim E, Hong WK, Lippman SM and Mao L: Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy. J Clin Oncol 26: 354-360, 2008. (Pubitemid 351171684)
10. Yuan P, Temam S, El-Naggar A, Zhou X, Liu DD, Lee JJ and Mao L: Overexpression of podoplanin in oral cancer and its association with poor clinical outcome. Cancer 107: 563-569, 2006. (Pubitemid 44107217)
11. Vormittag L, Thurnher D, Geleff S, Pammer J, Heiduschka G, Brunner M, Grasl MC and Erovic BM: Co-expression of Bmi-1 and podoplanin predicts overall survival in patients with squamous cell carcinoma of the head and neck treated with radio(chemo)therapy. Int J Radiat Oncol Biol Phys 73: 913-918, 2009.
12. Chung MK, Min JY, So YK, Ko YH, Jeong HS, Son YI and Baek CH: Correlation between lymphatic vessel density and regional metastasis in squamous cell carcinoma of the tongue. Head Neck 32: 445-451, 2010.
13. Kreppel M, Scheer M, Drebber U, Ritter L and Zöller JE: Impact of podoplanin expression in oral squamous cell carcinoma: clinical and histopathologic correlations. Virchows Arch 456: 473-482, 2010.
14. O'Donnell RK, Feldman M, Mick R and Muschel RJ: Immunohistochemical method identifies lymphovascular invasion in a majority of oral squamous cell carcinomas and discriminates between blood and lymphatic vessel invasion. J Histochem Cytochem 56: 803-810, 2008.
15. Naber U, Friedrich RE, Glatzel M, Mautner VF and Hagel C: Podoplanin and CD34 in peripheral nerve sheath tumours: focus on neurofibromatosis 1-associated atypical neurofibroma. J Neurooncol 103: 239-245, 2011.
16. Friedrich RE, Bartel-Friedrich S, Lobeck H, Niedobitek G and Arps H: Epsten-Barr virus DNA, intermediate filaments and epithelial membrane antigen in nasopharyngeal carcinoma. Anticancer Res 20: 4909-4916, 2000. (Pubitemid 32319052)
17. Kanner WA, Galgano MT and Atkins KA: Podoplanin expression in basal and myoepithelial cells: utility and potential pitfalls. Appl Immunohistochem Mol Morphol 18: 226-230, 2010.
18. Erovic BM, Neuchrist C, Kandutsch S, Woegerbauer M and Pammer J: CD9 expression on lymphatic vessels in head and neck mucosa. Mod Pathol 16: 1028-1034 2003. (Pubitemid 37280819)
19. Carbone A and Micheau C: Pitfalls in microscopic diagnosis of undifferentiated carcinoma of nasopharyngeal type (lymphoepithelioma). Cancer 50: 1344-1351, 1982. (Pubitemid 12031959)